印度新的5%或零GST在关键药品上将价格削减到10%,减轻病人的费用。 India's new 5% or zero GST on key medicines cuts prices up to 10%, easing costs for patients.

自9月22日起, Shimla药店已开始实施经修订的GST药品价格,将价格降低10%,为患者提供大量救济。 Shimla pharmacies have begun implementing revised GST rates on medicines, reducing prices by up to 10% effective September 22, offering significant relief to patients. 基本和救生药物,包括胰岛素和癌症治疗,现在的税率为5%或免税,取代了原来的12%和18%的板块。 Essential and life-saving drugs, including insulin and cancer treatments, are now taxed at 5% or exempt, replacing the previous 12% and 18% slabs. 消费者报告立即节约,一些药品下降数百卢比。 Consumers report immediate savings, with some medications dropping by hundreds of rupees. 药店业主和官员表示, 改变能提高可负担性, 鼓励遵守GST, 并提升消费, Pharmacy owners and officials say the change improves affordability, encourages GST compliance, and boosts consumption, benefiting both patients and the government in the long term.